- Recent FDA Approvals
- Olezarsen approved for familial chylomicronemia syndrome treatment
- Tirizepatide approved for moderate-to-severe sleep apnea in obese adults
- Ensacove approved for ALK-positive non-small cell lung cancer
- Crenecerfont approved for adrenal insufficiency in children
- Remestemcel-L-rknd approved for pediatric GVHD treatment
- Clinical Decision Support
- DynaMed Decisions offers evidence-based clinical decision support
- Free breast cancer treatment comparison tool available
- Internet Explorer support discontinued October 7, 2024
- Recognition and Training
- Ranked number one in KLAS Research's 2024 Clinical Decision Support
- Content eligible for DEA training requirements
- Some topics accepted for AMA PRA Category 1 Credit™